QTTB Latest Press Releases

-- February 19, 2026 --

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Ra, and Others | DelveInsight PRNewswire 5:31 PM

-- February 18, 2026 --

Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference PRNewswire 6:59 AM

-- February 17, 2026 --

Q32 Bio Announces $10.5 Million Registered Direct Offering PRNewswire 6:59 AM

-- December 1, 2025 --

Q32 Bio Sells Complement Inhibitor ADX-097 PRNewswire 7:00 AM

Akebia Announces Establishment of Rare Kidney Disease Pipeline Globe Newswire 7:00 AM

-- November 13, 2025 --

Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update PRNewswire 6:59 AM

-- October 21, 2025 --

Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata PRNewswire 6:59 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software